LIFECORE BIOMEDICAL, INC. Repayments of Other Debt
LIFECORE BIOMEDICAL, INC. (LFCR) reported Repayments of Other Debt of $232.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2025-11-06
- LIFECORE BIOMEDICAL, INC. repayments of other debt for the quarter ending 2025-09-30 was $232.00K.
- LIFECORE BIOMEDICAL, INC. repayments of other debt for the quarter ending 2025-05-25 was $231.00K, a 0.43% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. repayments of other debt for the quarter ending 2025-02-23 was $313.00K, a 8.30% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. repayments of other debt for the quarter ending 2024-11-24 was $153.00K, a 20.73% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. repayments of other debt for fiscal 2025 was $930.00K, a 30.25% increase from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. repayments of other debt for fiscal 2024 was $714.00K.
- LIFECORE BIOMEDICAL, INC. repayments of other debt for fiscal 2023 was $0.00.
- LIFECORE BIOMEDICAL, INC. repayments of other debt for fiscal 2022 was $0.00.
| Period end | Repayments of Other Debt 3 month | Repayments of Other Debt 3 month as first filed | Repayments of Other Debt 6 month | Repayments of Other Debt 9 month | Repayments of Other Debt 12 month | Repayments of Other Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | $232.00K 10-Q · filed 2025-11-06 | |||||
| 2025-05-25 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07 | $544.00K derived: sum of 2 quarters · filed 2025-08-07 | $697.00K derived: sum of 3 quarters · filed 2025-08-07 | $930.00K 10-K · filed 2025-08-07 | ||
| 2025-02-23 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03 | $466.00K derived: sum of 2 quarters · filed 2025-04-03 | $699.00K 10-Q · filed 2025-04-03 | $931.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-11-24 | $153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $386.00K 10-Q · filed 2025-01-02 | $618.00K derived: sum of 3 quarters · filed 2025-11-06 | $907.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-08-25 | $233.00K 10-Q · filed 2025-11-06 | $193.00K 10-Q · filed 2024-10-04 | $465.00K derived: sum of 2 quarters · filed 2025-11-06 | $754.00K derived: sum of 3 quarters · filed 2025-11-06 | $947.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-05-26 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07 | $521.00K derived: sum of 2 quarters · filed 2025-08-07 | $714.00K derived: sum of 3 quarters · filed 2025-08-07 | $714.00K 10-K · filed 2025-08-07 | $579.00K 10-K · filed 2024-08-26 | |
| 2024-02-25 | $289.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03 | $482.00K derived: sum of 2 quarters · filed 2025-04-03 | $482.00K 10-Q · filed 2025-04-03 | |||
| 2023-11-26 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $193.00K 10-Q · filed 2025-01-02 | ||||
| 2023-08-27 | $0.00 10-Q · filed 2024-10-04 | |||||
| 2023-05-28 | $0.00 10-K · filed 2024-08-26 | |||||
| 2022-05-29 | $0.00 10-K · filed 2024-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |